James Hardie (NYSE: JHX) director plans NYSE share sales via family trusts

Rhea-AI Filing Summary

James Hardie Industries plc (symbol JHX) received a Rule 144 notice covering proposed sales of its common stock for the account of director Jesse Singh, with Goldman Sachs & Co. LLC acting as broker. The notice reports 221,457 shares of common stock, with an aggregate market value of $6,738,936.51, and 580,336,768 shares outstanding as of August 21, 2026; this is a baseline figure, not the amount being sold. Planned sales include 103,400 shares to be sold by the Jesse Singh 2024 GRAT and additional shares to be sold by the Jesse Singh 2016 Irrevocable Trust, all on the NYSE.

Key Figures

Reported shares: 221,457 shares of common stock Aggregate market value: $6,738,936.51 Shares outstanding: 580,336,768 shares +1 more

4 metrics

Reported shares 221,457 shares of common stock Shares associated with the Rule 144 notice

Aggregate market value $6,738,936.51 Aggregate market value of reported James Hardie Industries plc common stock

Shares outstanding 580,336,768 shares Common stock outstanding as of August 21, 2026

Planned sale from 2024 GRAT 103,400 shares Shares to be sold by the Jesse Singh 2024 GRAT

Key Terms

Rule 144, GRAT, Irrevocable Trust

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

GRAT financial

"103,400 shares to be sold by Jesse Singh 2024 GRAT."

Irrevocable Trust financial

"118,457 shares to be sold by Jesse Singh 2016 Irrevocable Trust."

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What does the Form 144 filing for JHX disclose about planned share sales?

The filing discloses an intent to sell James Hardie Industries plc common stock under Rule 144 for the account of director Jesse Singh, including 103,400 shares held in the Jesse Singh 2024 GRAT, with additional shares from a 2016 Irrevocable Trust.

How many JHX shares and what value are reported in the Form 144?

The notice reports 221,457 shares of James Hardie Industries plc common stock with an aggregate market value of $6,738,936.51. These figures describe the position associated with the filing, not necessarily the exact amount to be sold.

How many James Hardie Industries plc (JHX) shares are outstanding?

The filing reports that 580,336,768 shares of James Hardie Industries plc common stock were outstanding as of August 21, 2026, providing context for the size of the reported holdings and planned sales.

Who is selling JHX shares under this Form 144 and in what capacity?

The shares are to be sold for the account of Jesse Singh, identified as a director of James Hardie Industries plc. Some shares are held through the Jesse Singh 2024 GRAT and the Jesse Singh 2016 Irrevocable Trust.

Which broker is handling the planned JHX share sales in this Form 144?

The planned sales of James Hardie Industries plc common stock are to be executed through Goldman Sachs & Co. LLC, which is listed as the broker and also signs the notice on behalf of Jesse Singh.

On which exchange are the JHX shares in this Form 144 listed?

The common stock referenced in the Form 144 for James Hardie Industries plc is listed on the NYSE, as stated in the securities information section of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 05:13 PM Accepted by SEC EDGAR 08/21/2026 - 05:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001594032
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	James Hardie Industries plc
SEC File Number	001-15240
Address of Issuer	1st Floor, Block A, One Park Place Upper Hatch Street Dublin IRELAND D02 FD79
Phone	353-1411-6924
Name of Person for Whose Account the Securities are To Be Sold	Jesse Singh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	221457	6738936.51	580336768	08/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/02/2025	Acquired as consideration of merger or acquisition	Issuer			103400	07/02/2025	Securities
Common Stock	07/02/2025	Acquired as consideration of merger or acquisition	Issuer			118057	07/02/2025	Securities

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	103,400 shares to be sold by Jesse Singh 2024 GRAT. 118,457 shares to be sold by Jesse Singh 2016 Irrevocable Trust.
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Jesse Singh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)